Aldeyra Therapeutics Sued for Securities Fraud

Investors urged to contact law firm about potential class action lawsuit

Mar. 31, 2026 at 6:32pm

Got story updates? Submit your updates here. ›

A close-up, high-contrast black-and-white image of complex financial machinery, conveying a sense of the power and security of the financial system.A lawsuit alleging securities fraud at a biotech firm exposes the high-stakes, high-security world of modern finance.Boston Today

Aldeyra Therapeutics, Inc., a biotechnology company focused on the development of novel therapies for immune-mediated diseases, has been sued for securities fraud. The lawsuit, filed by the law firm Block & Leviton, alleges that the company made false and misleading statements about its financial performance and the progress of its drug development programs.

Why it matters

The lawsuit against Aldeyra Therapeutics is significant as it raises concerns about the company's transparency and accountability to its investors. Securities fraud cases can have far-reaching consequences, potentially impacting the company's stock price, reputation, and ability to raise future funding.

The details

The lawsuit alleges that Aldeyra Therapeutics made false and misleading statements about the progress of its drug development programs, as well as its financial performance. The law firm is urging investors who purchased Aldeyra's stock to contact them to discuss the potential for a class action lawsuit.

  • The lawsuit was filed on March 31, 2026.

The players

Aldeyra Therapeutics, Inc.

A biotechnology company focused on the development of novel therapies for immune-mediated diseases.

Block & Leviton

A law firm that has filed the securities fraud lawsuit against Aldeyra Therapeutics.

Got photos? Submit your photos here. ›

What’s next

The judge will decide on whether to certify the case as a class action lawsuit in the coming weeks.

The takeaway

This lawsuit highlights the importance of transparency and accountability for publicly traded companies, as investors rely on accurate information to make informed decisions about their investments.